Latest Updates

Lupin launches generic Atovaquone oral suspension USP in the US

Read more

InvaGen in agreement with Avenue Therapeutics for specialty hospital business in the US

Read more

DRL’s Duvvada unit undergoes German regulator’s follow-on-audit

Read more

Flexible biopatch can deliver precise drug dosage

Read more

Zydus Cadila gets US FDA nod for anti-fungal ointment

Read more

Cipla receives final approval for generic version of Roche’s Valcyte

Read more

Wockhardt Q2 net loss widens to ₹ 23 crore

Read more

Novartis division Sandoz recalls one lot of blood pressure drug

Read more

Mylan and Theravance’s COPD treatment gets FDA approval

Read more

Glenmark to launch trial in solid tumours for its CD38xCD3 bispecific antibody GBR 1342

Read more